Preparation method of high-purity dextroborneol

By using (R)-2-methyl-CBS-oxazolborane catalyst and boron anhydride to reduce dextrorotatory camphor, combined with recrystallization, the problem of high-purity dextrorotatory alcohol in the prior art has been solved, and the preparation of high-purity dextrorotatory alcohol has been achieved, which is suitable for pharmaceutical grade products.

CN119039104APending Publication Date: 2024-11-29SICHUAN AOBANG GUDE PHARM CO LTD +1

Patent Information

Application Number
CN202410739817.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-07
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

Existing technologies make it difficult to prepare high-purity dexborneol, especially isoborneol, which has a high impurity content and cannot meet the requirements for pharmaceutical-grade dexborneol.

Method used

Using (R)-2-methyl-CBS-oxazolborane as a catalyst and a boron anhydride as a reducing agent, dextrorotatory camphor was reduced under specific temperature and solvent conditions, and then purified by recrystallization to prepare high-purity dextrorotatory camphor.

Benefits of technology

Dexborneol with a dr value ≥ 98.5% and a purity ≥ 98.5% was prepared, meeting the pharmacopoeia standards and suitable as the active ingredient for concentrated edaravone dexborneol injection solution.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119039104A_ABST
    Figure CN119039104A_ABST
Patent Text Reader

Abstract

The invention provides a preparation method of high-purity dextrocamphor. The preparation method comprises the following steps: reducing dextrocamphor in the presence of (R)-2-methyl-CBS-oxazole borane; wherein the reducing agent for reducing the dextro-camphor is a negative hydrogen compound of boron. According to the present invention, the preparation method is simple, the selectivity of the target product is high, the product with the dr value of more than or equal to 98.5% can be prepared, the dextroborneol with the purity of more than or equal to 98.5% can be obtained through recrystallization, the quality is significantly higher than the pharmacopeia standard, the requirement of the injection drug can be met, and the dextroborneol can be used as the active component of the edaravone dextroborneol injection concentrated solution.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical fields of medicine and chemistry, and in particular to a method for preparing high-purity borneol. Background Art

[0002] Borneol (also known as borneol) forms different isomers according to the spatial position of its hydroxyl group and the position of the geminal dimethyl group, as follows:

[0003]

[0004] Dextrorotatory borneol (also known as d-borneol) is a colorless, transparent or white flaky solid. It is a natural bicyclic monoterpene used for analgesia and anesthesia in traditional Chinese medicine. It is also the active ingredient of the concentrated solution of edaravone dextrorotatory borneol for injection. Dextrorotatory borneol can be extracted from the leaves of camphor camphor, but the extraction rate is less than 2%, and the extracted dextrorotatory borneol has a high impurity content. Specifically, it contains a high content of camphor (about 3%). The Pharmacopoeia of the People's Republic of China (2020 edition) stipulates that the dextrorotatory borneol extracted and processed from the fresh branches and leaves of the Lauraceae plant camphor Cinnamomumcamphora (L) Presl is detected by gas chromatography, and the content shall not be less than 96%. Dextrorotatory borneol (d-borneol) extracted from natural plants is difficult to use as an active ingredient in the concentrated solution of edaravone dextrorotatory borneol for injection due to its low purity. Chemically synthesized borneol is generally a mixture of right- and left-borneol. In addition, it also contains a large number of diastereomeric impurities (isoborneol, including left- and right-rotating isoborneol). Isoborneol can cause liver damage. Therefore, borneol synthesized by traditional chemical methods cannot meet the demand for pharmaceutical-grade right-borneol. The development of a method for preparing high-purity right-borneol has significant practical and economic significance.

[0005] There are two common chemical synthesis methods for preparing right-borneol in the prior art: esterification-saponification method and camphor reduction method. Among them, the esterification-saponification method is to use α-pinene as a raw material to form a carbon cation in the presence of a catalyst, and then esterify with an organic acid or anhydride and distill to obtain a borneol ester; the borneol ester is hydrolyzed and steam distilled to obtain a racemic borneol. The synthesis route is as follows:

[0006]

[0007] However, in the process of preparing borneol by the existing esterification-saponification method, carbon chain rearrangement occurs in the stage of converting α-pinene into carbon cations to form isoborneol esters or fenchol esters; in the esterification stage, part of the pinene will also be isomerized into monoterpene compounds such as dipentene or polymerized into oligomers, ultimately resulting in a high content of isoborneol in the product, which is difficult to separate and has low medicinal value; currently, the best borneol yield of the esterification-saponification method does not exceed 70%, and a large amount of isoborneol is still present in the product, and it is impossible to obtain high-purity borneol through conventional crystallization.

[0008] Among them, the camphor reduction method uses right-handed camphor (natural camphor) as raw material, which is reduced to borneol in the presence of a catalyst. The synthetic route is as follows:

[0009]

[0010] However, in the method disclosed in the prior art for reducing right-handed camphor with alkali metal in ethanol or ammonia to obtain borneol, the chiral purity of the product does not exceed 70%, and the reaction needs to be carried out at -40°C, which is a harsh condition. The alkali metal reaction is very violent and difficult to control in industry. In the method disclosed in the prior art for obtaining borneol using triisopropylaluminum / isopropanol and sodium borohydride right-handed camphor, the main impurity is isoborneol, and most of the impurities are difficult to separate.

[0011] In summary, there is an urgent need to provide a method for preparing high-purity borneol, especially a method for preparing isoborneol with low impurity content. Summary of the invention

[0012] In view of the shortcomings of the prior art, the purpose of the present invention is to provide a method for preparing high-purity dextroborneol. The present invention not only has a simple preparation method, but also has high selectivity for the target product, and can prepare a product with a dr value of ≥98.5%. Dextroborneol with a purity of ≥98.5% can be obtained by recrystallization, and the quality is significantly higher than the pharmacopoeia standard, can meet the requirements of injection drugs, and can be used as an active ingredient of a concentrated solution of edaravone and dextroborneol for injection.

[0013] The purpose of the present invention is achieved through the following technical solutions:

[0014] In a first aspect, the present invention provides a method for preparing high-purity borneol, the method comprising reducing right-rotating camphor in the presence of (R)-2-methyl-CBS-oxazaborolidine. (R)-2-methyl-CBS-oxazaborolidine is used as a catalyst for reducing right-rotating camphor to prepare borneol, which can improve the selectivity of borneol.

[0015] In some embodiments of the present invention, the molar ratio of dextrorotatory camphor to (R)-2-methyl-CBS-oxazaborolidine is 1:2 to 2:1, preferably 1:1.

[0016] In some embodiments of the present invention, the reducing agent for reducing right-rotatory camphor is a boron negative hydrogen compound; preferably, the boron negative hydrogen compound includes an organic boron negative hydrogen compound and an inorganic boron negative hydrogen compound.

[0017] In some embodiments of the present invention, during the preparation process, the molar ratio of the reducing agent used, calculated as boron, to the dextrorotatory camphor is 1:3 to 3:1, preferably 1:2 to 2:1, and more preferably 1:1.

[0018] In some embodiments of the present invention, the organic boron hydrogen compound comprises borane.

[0019] In some embodiments of the present invention, the inorganic boron negative hydrogen compound includes one or two of sodium borohydride, potassium borohydride, etc.

[0020] In some embodiments of the present invention, the reduction reaction of right-rotatory camphor is carried out in the presence of a reduction active compound formed by complexing (R)-2-methyl-CBS-oxazaborolidine with a negative hydrogen compound of boron.

[0021] In some embodiments of the present invention, the molar ratio of the boron negative hydrogen compound to the (R)-2-methyl-CBS-oxazaborolidine is 1:2 to 2:1, preferably 1:1.

[0022] In some embodiments of the present invention, the reaction conditions for reducing right-rotatory camphor include: the reaction temperature is -40 to 10°C, preferably -30 to 0°C, more preferably -30 to -20°C or -10 to 0°C; the reaction time is 1 to 10 hours, preferably 2 to 8 hours, more preferably 4 to 6 hours.

[0023] In some embodiments of the present invention, the reduction of right-rotatory camphor is carried out in the presence of a solvent; preferably, the solvent is an anhydrous solvent; more preferably, the solvent is an organic solvent, preferably including any one or more of diethyl ether, tetrahydrofuran, dichloromethane, toluene, etc.

[0024] In some embodiments of the present invention, the preparation method comprises the following steps:

[0025] (1) adding a solvent, right-rotating camphor, and (R)-2-methyl-CBS-oxazaborolidine into a reactor;

[0026] (2) dispersing the organic boron hydrogen compound in an organic solvent, then cooling the reaction solution of step (1) to -30 to -20°C, adding the organic solvent containing the organic boron hydrogen compound to the reaction solution, controlling the temperature of the reaction solution to -30 to -20°C and reacting for 1 to 10 hours;

[0027] Preferably, the organic solvent in step (2) can be selected from any one or more of diethyl ether, tetrahydrofuran, dimethyl sulfide, etc.

[0028] In some embodiments of the present invention, the preparation method comprises the following steps:

[0029] (I) adding a solvent, an inorganic boron hydrogen compound, and (R)-2-methyl-CBS-oxazaborolidine into a reactor and reacting for 1 to 2 hours;

[0030] (II) The reaction solution of step (I) is cooled to -10 to 0°C, and dextrorotatory camphor is added to the reaction solution. Preferably, the dextrorotatory camphor is added to the reaction solution in batches, and the temperature of the reaction solution is controlled to be -10 to 0°C for 1 to 8 hours.

[0031] In some embodiments of the present invention, in the above-described preparation method, (R)-2-methyl-CBS-oxazaborolidine can be directly added to the reactor in its solid form, or it can be first dispersed in an organic solvent and then added to the reactor. Preferably, the organic solvent for dispersing (R)-2-methyl-CBS-oxazaborolidine is selected from any one or more of toluene, tetrahydrofuran, diethyl ether, etc.

[0032] In some embodiments of the present invention, the preparation method described above also includes a purification step after the reaction is completed; preferably, the purification step includes: adding water to the reaction solution to quench the reaction and then recovering the organic layer, then washing the organic layer with an acidic solution and an alkaline solution, respectively, and then washing with pure water, and finally concentrating the organic layer to dryness and adding an organic solvent for recrystallization to obtain a high-purity target product.

[0033] In some embodiments of the present invention, concentrating the organic layer to dryness is performed at 10-80°C.

[0034] In some embodiments of the present invention, the organic solvent used for recrystallization is selected from any one or more of n-heptane, ether, tetrahydrofuran, dichloromethane, toluene, etc.; preferably n-heptane.

[0035] In some embodiments of the present invention, the recrystallization is performed at -30 to 30°C.

[0036] In some embodiments of the present invention, in the above-mentioned washing of the organic layer with an acidic solution and an alkaline solution, the order of washing with the acidic solution and washing with the alkaline solution is not limited; wherein the acidic solution is preferably a hydrochloric acid solution, more preferably a 1.0M hydrochloric acid solution; the alkaline solution is preferably a sodium hydroxide solution, more preferably a 1.0M sodium hydroxide solution.

[0037] In a second aspect, the present invention provides borneol prepared by the preparation method described in the first aspect; preferably, the dr value of the borneol is ≥98.5%; more preferably, the purity of the borneol is ≥98.5%.

[0038] In a third aspect, the present invention provides a use of the dextroborneol described in the second aspect in the preparation of a concentrated solution of edaravone and dextroborneol for injection.

[0039] The beneficial effects of the present invention are as follows:

[0040] The present invention proposes a method for preparing high-purity right-borneol by reducing right-rotating camphor with (R)-2-methyl-CBS-oxazaborolidine as a catalyst. In the preparation process, due to the presence of (R)-2-methyl-CBS-oxazaborolidine, the selectivity of right-borneol can be effectively improved. The present invention also proposes to use a negative hydrogen compound of boron as a reducing agent to reduce right-rotating camphor to prepare high-purity right-borneol. When (R)-2-methyl-CBS-oxazaborolidine and a negative hydrogen compound of boron are present in the reaction solution at the same time, the reduction active compound formed by the complexation of (R)-2-methyl-CBS-oxazaborolidine and the negative hydrogen compound of boron can significantly improve the selectivity of right-rotating camphor to right-borneol, especially can reduce the content of isoborneol in the reaction product. In addition, the inventors of the present invention found that when an inorganic negative hydrogen compound of boron is selected as a reducing agent, the reaction temperature can be increased to above -10°C, which can significantly reduce the cost of maintaining a lower reaction temperature, and is more conducive to the industrial production of right-borneol.

[0041] The invention not only has a simple preparation method but also has high selectivity for the target product, and can prepare a product with a dr value of ≥98.5%, and then obtain dextroborneol with a purity of ≥98.5% through recrystallization, the quality of which is significantly higher than the pharmacopoeia standard, can meet the requirements of injection drugs, and can be used as an active ingredient of an edaravone dextroborneol concentrated solution for injection. BRIEF DESCRIPTION OF THE DRAWINGS

[0042] Figure 1 This is the NMR-H spectrum of the product d-borneol (d-borneol) obtained in Example 4;

[0043] Figure 2 This is the NMR-C spectrum of the product d-borneol (d-borneol) obtained in Example 4;

[0044] Figure 3 It is the gas phase spectrum of the product d-borneol (d-borneol) obtained in Example 4;

[0045] Figure 4 is the gas phase spectrum of the product obtained in Comparative Example 1; DETAILED DESCRIPTION

[0046] The following examples further illustrate the technology of the present invention. These examples are for illustration and example of the present invention and are not intended to limit the scope of the present invention in any form.

[0047] Example 1

[0048] Preparation of high purity borneol

[0049] Add 1500mL (15V / m) of toluene to a 5L reaction bottle, and add 100g (0.66mol) of right-rotatory camphor and 660mL (0.66mol, 1.0eq) of (R)-2-methyl-CBS-oxazaborolidine-toluene solution (1.0M) under stirring; cool the reaction solution to -30°C, add dropwise 1320mL (1.32mol, 2.0eq) of borane-ether solution (1.0M) and control the temperature of the reaction solution to -30 to -20°C during the addition process; after the addition is complete, control the temperature of the reaction solution to -30 to -20°C for reaction, monitor the reaction using TLC, and when the reaction solution develops color, add dropwise 1000mL (10V / m) of drinking water to quench the reaction (control the temperature of the reaction solution to ≤10°C during the addition of drinking water). After the reaction is completed, 1000 mL (10 V / m) of n-heptane is added to extract the reaction solution, and the mixture is allowed to stand for separation after stirring. The organic layer is recovered and washed twice with 1000 mL of 1.0 M sodium hydroxide solution, 1000 mL of 1.0 M hydrochloric acid, and 1000 mL of drinking water, and then concentrated to dryness under reduced pressure at 40° C., 200 mL (2 V / m) of n-heptane is added to dissolve it, and the temperature is lowered to 0° C. and recrystallized to obtain 93.8 g of white solid borneol. After analysis, the purity of the product is 98.83%, which meets the pharmacopoeia standard of d-borneol.

[0050] Example 2

[0051] Preparation of high purity borneol

[0052] Add 1500mL (15V / m) of tetrahydrofuran to a 5L reaction bottle, and add 100g (0.66mol) of right-rotatory camphor and 1000mL (1.0mol, 1.5eq) of (R)-2-methyl-CBS-oxazaborolidine-toluene solution (1.0M) under stirring; cool the reaction solution to -30°C, add 1320mL (1.32mol, 2.0eq) of borane-ether solution (1.0M) dropwise, and control the temperature of the reaction solution to -30 to -20°C during the addition process; after the addition is complete, control the temperature of the reaction solution to -30 to -20°C for reaction, monitor the reaction using TLC, and when the reaction solution develops color, add 1000mL (10V / m) of drinking water to quench the reaction (control the temperature of the reaction solution to ≤10°C during the addition of drinking water). After the reaction is completed, 1000 mL (10 V / m) of n-heptane is added to extract the reaction solution, and the mixture is allowed to stand for separation after stirring. The organic layer is recovered and washed twice with 1000 mL of 1.0 M sodium hydroxide solution, twice with 1000 mL of 1.0 M hydrochloric acid, and twice with 1000 mL of drinking water, and then concentrated to dryness under reduced pressure at 40° C., dissolved in 200 mL (2 V / m) of n-heptane, cooled to 0° C., and recrystallized to obtain 91.8 g of white solid borneol. After analysis, the purity of the product was 98.74%, which met the pharmacopoeia standard for d-borneol.

[0053] Example 3

[0054] Preparation of high purity borneol

[0055] Add 1000mL (10V / m) of tetrahydrofuran to a 3L reaction bottle, add 24.8g (0.66mol, 1.0eq) of sodium borohydride under stirring, add 1000mL (1.0mol, 1.5eq) of (R)-2-methyl-CBS-oxazaborol-toluene solution (1.0M) after the addition, react for 1h, cool the reaction solution to -10°C, control the temperature of the reaction solution to -10~0°C during the addition process, and add 100.0g (0.66mol) of right-rotating camphor in batches. After the addition, control the temperature of the reaction solution to -10~0°C to continue the reaction, monitor the reaction using TLC, and when the reaction solution develops color, add 200mL (10V / m) of drinking water to quench the reaction (control the temperature of the reaction solution ≤10°C during the addition of drinking water). After the reaction is completed, 1000 mL (10 V / m) of n-heptane is added to extract the reaction solution, and the mixture is allowed to stand for separation after stirring. The organic layer is recovered and washed twice with 1000 mL of 1.0 M sodium hydroxide solution, twice with 1000 mL of 1.0 M hydrochloric acid, and twice with 1000 mL of drinking water, and then concentrated to dryness under reduced pressure at 40° C., dissolved with 200 mL (2 V / m) of n-heptane, cooled to 0° C., and recrystallized to obtain 78.5 g of white solid borneol. After analysis, the purity of the product was 98.78%, which met the pharmacopoeia standard for d-borneol.

[0056] Example 4

[0057] Preparation of high purity borneol

[0058] Add 1000 mL (10 V / m) of tetrahydrofuran to a 3 L reaction bottle, add 35.2 g (0.66 mol, 1.0 eq) of potassium borohydride under stirring, add 277.2 g (1.0 mol, 1.5 eq) of (R)-2-methyl-CBS-oxazaborolidine solid after the addition, react for 1 h, cool the reaction solution to -10°C, control the reaction solution temperature to -10 to 0°C, add 100.0 g (0.66 mol) of right-rotatory camphor in batches, control the reaction solution temperature to -10 to 0°C after the addition, and continue the reaction. Monitor the reaction by TLC, and when the reaction solution develops color, add 200 mL (10 V / m) of drinking water to quench the reaction (control the reaction solution temperature ≤10°C during the addition of drinking water). After the reaction is completed, 1000 mL (10 V / m) of n-heptane is added to extract the reaction solution, and the mixture is allowed to stand for separation after stirring. The organic layer is recovered and washed twice with 1000 mL of 1.0 M sodium hydroxide solution, 1000 mL of 1.0 M hydrochloric acid, and 1000 mL of drinking water, respectively. The mixture is then concentrated to dryness under reduced pressure at 40° C., 200 mL (2 V / m) of n-heptane is added to dissolve the mixture, and the mixture is cooled to 0° C. and recrystallized to obtain 86.5 g of white solid borneol. The product has a purity of 98.63% and meets the pharmacopoeia standard for d-borneol.

[0059] Comparative Example 1

[0060] Preparation of borneol

[0061] Add 1000mL (10V / m) of tetrahydrofuran to a 3L reaction bottle, add 24.8g (0.66mol, 1.0eq) of sodium borohydride under stirring, add 128.2g of boron trifluoride-tetrahydrofuran solution (48% w / w) dropwise and control the temperature of the reaction liquid to 0-10°C during the addition, cool the reaction liquid to -10°C, add 100.0g (0.66mol) of right-rotatory camphor in batches and control the temperature of the reaction liquid to -10-0°C during the addition, control the temperature of the reaction liquid to -10-0°C after the addition, and react, monitor the reaction using TLC, and when the reaction liquid develops color, add 1000mL (10V / m) of drinking water to quench the reaction (control the temperature of the reaction liquid to ≤10°C during the addition of drinking water). After the reaction is completed, 1000 mL (10 V / m) of n-heptane is added to extract the reaction solution, stirred evenly, and then allowed to stand for separation. The organic layer is recovered and washed twice with 1000 mL of 1.0 M sodium hydroxide solution, 1000 mL of 1.0 M hydrochloric acid, and 1000 mL of drinking water, and then concentrated to dryness under reduced pressure at 40° C., 200 mL (2 V / m) of n-heptane is added, and the temperature is lowered to 0° C. to recrystallize to obtain 92.6 g of white solid borneol (KC1-231007A1), with a purity of 45.09% and containing 53.506+0.486=53.99% of isoborneol (including left-handed isoborneol and right-handed isoborneol). The purity of d-borneol is lower.

[0062] The method for monitoring the reaction using TLC in the above Examples 1-4 and Comparative Example 1 is: the developing solvent V( 正庚烷 ):V( 乙酸乙酯 )=5:1; 5% phosphomolybdic acid ethanol solution for color development.

[0063] It should be noted that the embodiments described above are only used to explain the present invention and do not constitute any limitation of the present invention. The present invention has been described with reference to the embodiments, but it should be understood that the words used therein are descriptive and explanatory words, rather than restrictive words. The present invention may be modified as specified within the scope of the claims of the present invention, and the present invention may be revised without departing from the scope and spirit of the present invention. Although the present invention described therein relates to specific methods, materials and embodiments, it does not mean that the present invention is limited to the specific examples disclosed therein, on the contrary, the present invention can be extended to all other methods and applications with the same functions.

Claims

1. A method for preparing high-purity borneol, characterized in that: The preparation method comprises reducing right-rotating camphor in the presence of (R)-2-methyl-CBS-oxazaborolidine.

2. The preparation method according to claim 1, characterized in that: The reducing agent for reducing right-rotating camphor is a boron hydrogen compound; preferably, the boron hydrogen compound includes an organic boron hydrogen compound and an inorganic boron hydrogen compound; wherein the organic boron hydrogen compound includes borane; and the inorganic boron hydrogen compound includes: one or two of sodium borohydride and potassium borohydride.

3. The preparation method according to claim 2, characterized in that: The reduction reaction of right-rotatory camphor is carried out in the presence of a reduction active compound formed by complexing (R)-2-methyl-CBS-oxazaborolidine with a negative hydrogen compound of boron.

4. The preparation method according to any one of claims 1 to 3, characterized in that The reaction conditions for reducing right-rotatory camphor include: a reaction temperature of -40 to 10°C, preferably -30 to 0°C, more preferably -30 to -20°C or -10 to 0°C; a reaction time of 1 to 10 hours, preferably 2 to 8 hours, more preferably 4 to 6 hours.

5. The preparation method according to any one of claims 1 to 4, characterized in that: The reduction of right-rotatory camphor is carried out in the presence of a solvent; preferably, the solvent is an anhydrous solvent; more preferably, the solvent is an organic solvent, preferably including any one or more of diethyl ether, tetrahydrofuran, dichloromethane, and toluene.

6. The preparation method according to any one of claims 1 to 5, characterized in that The preparation method comprises the following steps: (1) adding a solvent, right-rotating camphor, and (R)-2-methyl-CBS-oxazaborolidine into a reactor; (2) dispersing the organic boron hydrogen compound in an organic solvent, then cooling the reaction solution of step (1) to -30 to -20°C, adding the organic solvent containing the organic boron hydrogen compound to the reaction solution, controlling the temperature of the reaction solution to -30 to -20°C and reacting for 1 to 10 hours; Preferably, the organic solvent in step (2) can be selected from any one or more of diethyl ether, tetrahydrofuran, and dimethyl sulfide.

7. The preparation method according to any one of claims 1 to 5, characterized in that The preparation method comprises the following steps: (I) adding a solvent, an inorganic boron hydrogen compound, and (R)-2-methyl-CBS-oxazaborolidine to a reactor, and reacting at 0-40° C. for 1-2 hours; (II) The reaction solution of step (I) is cooled to -10 to 0°C, and dextrorotatory camphor is added to the reaction solution. Preferably, the dextrorotatory camphor is added to the reaction solution in batches, and the temperature of the reaction solution is controlled to be -10 to 0°C for 1 to 8 hours.

8. The preparation method according to claim 6 or 7, characterized in that: The preparation method further comprises a purification step after the reaction is completed; preferably, the purification step comprises: adding water to the reaction solution to quench the reaction, recovering the organic layer, then washing the organic layer with an acidic solution and an alkaline solution respectively, and then washing with pure water, and finally concentrating the organic layer to dryness and adding an organic solvent for recrystallization to obtain a high-purity target product; Preferably, the organic solvent used for recrystallization is selected from any one or more of n-heptane, ether, tetrahydrofuran, dichloromethane and toluene.

9. Borneol prepared by the preparation method according to any one of claims 1 to 8; preferably, the dr value of the borneol is ≥98.5%; more preferably, the purity of the borneol is ≥98.5%.

10. Use of the dextroborneol according to claim 9 in the preparation of a concentrated solution of edaravone and dextroborneol for injection.

Citation Information

Patent Citations

  • Improved method for preparing ezetimibe

    CN104402790A

  • Ivabradine chiral intermediate compound

    CN112724001A

  • Application of composition in treatment of cerebral apoplexy

    CN115803022A

  • Preparation method of d-borneol

    CN119661319A

  • Production of optically active alcohol

    JP2000169406A

Cited By

  • Synthetic method of borneol

    CN119462334A

  • A method for synthesizing borneol

    CN119462334B

  • Separation and detection method for enantiomer and diastereoisomer of dextroborneol

    CN119985804A

  • Dexhanol crystal form as well as preparation method and application thereof

    CN120717873A